2026 NIAID DMID Omnibus Broad Agency Announcement

Award Notice Posted

Solicitation number
HHS-NIH-NIAID-BAA2025-1
Agency
Awarded
to Arisan Therapeutics Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N93026C00012 Federal contract award

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases awarded contract 75N93026C00012 to Arisan Therapeutics Inc. for $23,878,987 on July 29, 2026, under the 2026 NIAID DMID Omnibus Broad Agency Announcement.

The award was made as a cost-reimbursement contract under full and open competition. Cost-reimbursement was selected because costs could not be adequately defined at the time of award.

Notice text

This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.

Awarded contract 75N93026C00012 to ARISAN THERAPEUTICS INC for 23878987.00 on 2026-07-29.

Notice history

Notice Type Posted
2026 NIAID DMID Omnibus Broad Agency Announcement Latest Award Notice
This notice Award Notice
2026 NIAID DMID Omnibus Broad Agency Announcement Award Notice
2026 NIAID DMID Omnibus Broad Agency Announcement Latest solicitation Solicitation
2026 NIAID DMID Omnibus Broad Agency Announcement Original Pre-Solicitation

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors